Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

20 treatments under study, led by Sertraline

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Phase 1/2 (1)
Phase 2 (1)

Trial Status

Completed2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT00262470Phase 1/2Active Not Recruiting

Treatment of Orthostatic Intolerance

NCT06133075Phase 2Completed

Using Mirabegron to Increase BP in Patients With POTS

NCT00581022Completed

Objective Sleep Disturbances in Orthostatic Intolerance

Showing all 3 trials

Research Network

Common Treatments

  • Sertraline1
  • Isosorbide Dinitrate1
  • Breathing Device1
  • Acetazolamide1
  • Modafinil1

Active Sponsors

  • Satish R. Raj2
  • Cedars-Sinai Medical Center1
  • National Center for Research Resources (NCRR)1
  • National Center for Advancing Translational Sciences (NCATS)1

Top Investigators

Related Conditions

  • Postural Orthostatic Tachycardia Syndrome1
  • Postural Tachycardia Syndrome1
  • Tachycardia1
  • Syncope1

Activity Timeline